{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:10:35Z","timestamp":1759342235543,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40257-016-0228-y","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T13:59:19Z","timestamp":1476280759000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cryofibrinogenemia-Induced Cutaneous Ulcers: A Review and Diagnostic Criteria"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5321-0584","authenticated-orcid":false,"given":"Ayman","family":"Grada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"issue":"9","key":"228_CR1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V10.9.945.945","volume":"10","author":"DR Korst","year":"1955","unstructured":"Korst DR, Kratochvil CH. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood. 1955;10(9):945\u201353.","journal-title":"Blood"},{"key":"228_CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM196011032631803","volume":"263","author":"JM Kalbfleisch","year":"1960","unstructured":"Kalbfleisch JM, Bird RM. Cryofibrinogenemia. N Engl J Med. 1960;263:881\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"228_CR3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjmed.2009.03.040","volume":"122","author":"D Saadoun","year":"2009","unstructured":"Saadoun D, et al. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med. 2009;122(12):1128\u201335.","journal-title":"Am J Med"},{"issue":"5","key":"228_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ajcp\/58.5.524","volume":"58","author":"SB Smith","year":"1972","unstructured":"Smith SB, Arkin C. Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature. Am J Clin Pathol. 1972;58(5):524\u201330.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"228_CR5","first-page":"290","volume":"13","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Cryofibrinogenemia after a liver transplant: first reported case posttransplant and a case-based review of the nontransplant literature. Exp Clin Transplant. 2015;13(3):290\u20134.","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"228_CR6","first-page":"203","volume":"61","author":"PA McKee","year":"1963","unstructured":"McKee PA, Kalbfleisch J, Bird R. Incidence and significance of cryofibrinogenemia. J Lab Clin Med. 1963;61(2):203\u201310.","journal-title":"J Lab Clin Med"},{"issue":"3","key":"228_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/RHU.0b013e318289e06e","volume":"19","author":"M Michaud","year":"2013","unstructured":"Michaud M, Pourrat J. Cryofibrinogenemia. J Clin Rheumatol. 2013;19(3):142\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"228_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.revmed.2009.12.019","volume":"32","author":"D Saadoun","year":"2011","unstructured":"Saadoun D, Musset L, Cacoub P. Les cryofibrinog\u00e9n\u00e9mies. Rev Med Interne. 2011;32(5):287\u201391.","journal-title":"Rev Med Interne"},{"key":"228_CR9","volume-title":"Fitzpatrick\u2019s dermatology in general medicine","author":"LA Goldsmith","year":"2012","unstructured":"Goldsmith LA, Fitzpatrick TB. Fitzpatrick\u2019s dermatology in general medicine. 8th ed. New York: McGraw-Hill Professional; 2012.","edition":"8"},{"issue":"10","key":"228_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jmg.26.10.631","volume":"26","author":"Y Lolin","year":"1989","unstructured":"Lolin Y, et al. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C. J Med Genet. 1989;26(10):631\u20136.","journal-title":"J Med Genet"},{"issue":"1","key":"228_CR11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1468-3083.1999.tb00808.x","volume":"12","author":"A Geest","year":"1999","unstructured":"Geest A, et al. Familial primary cryofibrinogenemia. J Eur Acad Dermatol Venereol. 1999;12(1):47\u201350.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"228_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/rheumatology\/35.1.102","volume":"35","author":"N Wulffraat","year":"1996","unstructured":"Wulffraat N, et al. Familial presence of primary cryofibrinogenaemia, a report of three cases. Rheumatology. 1996;35(1):102\u20133.","journal-title":"Rheumatology"},{"issue":"2","key":"228_CR13","first-page":"1","volume":"7","author":"P B\u00e9gin","year":"2011","unstructured":"B\u00e9gin P, et al. A large cohort of primary familial cryofibrinogenemia originates from the Magdalen Islands. Allergy Asthma Clin Immunol. 2011;7(2):1.","journal-title":"Allergy Asthma Clin Immunol."},{"issue":"2","key":"228_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2249.2000.01210.x","volume":"120","author":"H Blain","year":"2000","unstructured":"Blain H, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120(2):253\u201360.","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"228_CR15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.autrev.2011.04.009","volume":"10","author":"C Belizna","year":"2011","unstructured":"Belizna C, et al. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmun Rev. 2011;10(9):559\u201362.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"228_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/kem341","volume":"47","author":"C Belizna","year":"2008","unstructured":"Belizna C, et al. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology. 2008;47(2):205\u20137.","journal-title":"Rheumatology"},{"issue":"11","key":"228_CR17","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1093\/ndt\/gfr079","volume":"26","author":"B Terrier","year":"2011","unstructured":"Terrier B, et al. Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders. Nephrol Dial Transplant. 2011;26(11):3577\u201381.","journal-title":"Nephrol Dial Transplant"},{"issue":"732","key":"228_CR18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/pgmj.62.732.935","volume":"62","author":"M Barrett","year":"1986","unstructured":"Barrett M, et al. Cryofibrinogenaemia and acute gangrene in systemic sclerosis. Postgrad Med J. 1986;62(732):935\u20136.","journal-title":"Postgrad Med J"},{"issue":"7637","key":"228_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(70)91842-8","volume":"295","author":"J Pindyck","year":"1970","unstructured":"Pindyck J, Lichtman H, Kohl S. Cryofibrinogenaemia in women using oral contraceptives. Lancet. 1970;295(7637):51\u20133.","journal-title":"Lancet"},{"issue":"6","key":"228_CR20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2169\/internalmedicine.36.439","volume":"36","author":"K Hosoi","year":"1997","unstructured":"Hosoi K, et al. Cryofibrinogenemia with polyarthralgia, Raynaud\u2019s phenomenon and acral ulcer in a patient with Graves\u2019 disease treated with methimazole. Intern Med. 1997;36(6):439\u201342.","journal-title":"Intern Med"},{"issue":"1","key":"228_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3899\/jrheum.110793","volume":"39","author":"MS Soyfoo","year":"2012","unstructured":"Soyfoo MS, et al. Clinical significance of Cryofibrinogenemia: possible pathophysiological link with Raynaud\u2019s phenomenon. J Rheumatol. 2012;39(1):119\u201324.","journal-title":"J Rheumatol"},{"issue":"2","key":"228_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2249.2000.01210.x","volume":"120","author":"H Blain","year":"2000","unstructured":"Blain H, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exper Immunol. 2000;120(2):253\u201360.","journal-title":"Clin Exper Immunol."},{"issue":"6","key":"228_CR23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/art.1780390628","volume":"39","author":"HH Euler","year":"1996","unstructured":"Euler HH, et al. Monoclonal cryo-antifibrinogenemia. Arthritis Rheum. 1996;39(6):1066\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5 Pt 2","key":"228_CR24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/0190-9622(91)70275-7","volume":"25","author":"CC Zouboulis","year":"1991","unstructured":"Zouboulis CC, et al. Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. J Am Acad Dermatol. 1991;25(5 Pt 2):882\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"8763","key":"228_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0140-6736(91)90483-6","volume":"338","author":"VKRS Falanga","year":"1991","unstructured":"Falanga VKRS, et al. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet. 1991;338(8763):347\u20138.","journal-title":"Lancet"},{"issue":"1","key":"228_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1996.4791016.x","volume":"93","author":"P Rubegni","year":"1996","unstructured":"Rubegni P, et al. A case of cryofibrinogenaemia responsive to stanozolol. Br J Haematol. 1996;93(1):217\u20139.","journal-title":"Br J Haematol"},{"issue":"8","key":"228_CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2230.2000.00722.x","volume":"25","author":"F Revenga","year":"2000","unstructured":"Revenga F, et al. Cryofibrinogenaemia with a good response to stanozolol. Clin Exper Dermatol. 2000;25(8):621\u20133.","journal-title":"Clin Exper Dermatol."},{"issue":"5","key":"228_CR28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2015.08.071","volume":"74","author":"G Dabiri","year":"2016","unstructured":"Dabiri G, et al. Coagulation disorders and their cutaneous presentations: diagnostic work-up and treatment. J Am Acad Dermatol. 2016;74(5):795\u2013804.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"228_CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.revmed.2014.09.007","volume":"36","author":"M Michaud","year":"2015","unstructured":"Michaud M, et al. Cryofibrinogenemia: a single-center study at the University Hospital of Toulouse, France. Rev Med Interne. 2015;36(4):237\u201342.","journal-title":"Rev Med Interne"},{"issue":"9","key":"228_CR30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.autrev.2011.04.009","volume":"10","author":"C Belizna","year":"2011","unstructured":"Belizna C, et al. A 5-year prospective follow-up study in essential cryofibrinogenemia patients. Autoimmunity Rev. 2011;10(9):559\u201362.","journal-title":"Autoimmunity Rev"},{"issue":"Suppl 2","key":"228_CR31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/annrheumdis-2015-eular.6415","volume":"74","author":"T Shevtsova","year":"2015","unstructured":"Shevtsova T, et al. SAT0546 clinical manifestations and features of cryofibrinogenemia: Russian experience. Ann Rheum Dis. 2015;74(Suppl 2):857\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"228_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0002-9343(68)90238-6","volume":"44","author":"DA Miller","year":"1968","unstructured":"Miller DA, Freeman GL, Akers WA. Chronic urticaria: a clinical study of fifty patients. Am J Med. 1968;44(1):68\u201386.","journal-title":"Am J Med"},{"issue":"23","key":"228_CR33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJM196912042812308","volume":"281","author":"S Waxman","year":"1969","unstructured":"Waxman S, Dove JT. Cryofibrinogenemia aggravated during hypothermia. N Engl J Med. 1969;281(23):1291\u20132.","journal-title":"N Engl J Med"},{"issue":"12","key":"228_CR34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.bmt.1702678","volume":"26","author":"A Shimoni","year":"2000","unstructured":"Shimoni A, et al. Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2000;26(12):1343\u20135.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"228_CR35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jtv.2013.04.003","volume":"22","author":"G Dabiri","year":"2013","unstructured":"Dabiri G, Falanga V. Connective tissue ulcers. J Tissue Viability. 2013;22(4):92\u2013102.","journal-title":"J Tissue Viability."},{"issue":"5","key":"228_CR36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.amjmed.2003.09.033","volume":"116","author":"TD Amdo","year":"2004","unstructured":"Amdo TD, Welker JA. An approach to the diagnosis and treatment of cryofibrinogenemia. Am J Med. 2004;116(5):332\u20137.","journal-title":"Am J Med"},{"key":"228_CR37","volume-title":"Cutaneous wound healing","author":"V Falanga","year":"2001","unstructured":"Falanga V. Cutaneous wound healing. London: Martin Dunitz; 2001."},{"issue":"8909","key":"228_CR38","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(94)92497-X","volume":"343","author":"JS Greengard","year":"1994","unstructured":"Greengard JS, et al. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 1994;343(8909):1361\u20132.","journal-title":"Lancet"},{"key":"228_CR39","doi-asserted-by":"crossref","DOI":"10.3109\/9781841848785","volume-title":"Text atlas of wound management","author":"V Falanga","year":"2012","unstructured":"Falanga V, et al. Text atlas of wound management. Boca Raton: CRC Press; 2012."},{"issue":"2","key":"228_CR40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0190-9622(91)70048-7","volume":"24","author":"E Beightler","year":"1991","unstructured":"Beightler E, et al. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol. 1991;24(2):342\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"228_CR41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/archderm.1979.04010020054017","volume":"115","author":"S Martin","year":"1979","unstructured":"Martin S. Cryofibrinogenemia, monoclonal gammopathy, and purpura. Report of a case and review of the literature. Arch Dermatol. 1979;115(2):208\u201311.","journal-title":"Arch Dermatol"},{"issue":"2 Pt 2","key":"228_CR42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0190-9622(91)70048-7","volume":"24","author":"E Beightler","year":"1991","unstructured":"Beightler E, et al. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol. 1991;24(2 Pt 2):342\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"228_CR43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjmed.2015.03.009","volume":"128","author":"M Michaud","year":"2015","unstructured":"Michaud M, et al. Cryofibrinogenemia: a marker of severity of cryoglobulinemic vasculitis. Am J Med. 2015;128(8):916\u201321.","journal-title":"Am J Med"},{"issue":"1","key":"228_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0190-9622(93)70012-I","volume":"28","author":"RS Kirsner","year":"1993","unstructured":"Kirsner RS, et al. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol. 1993;28(1):71\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"228_CR45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pbc.22469","volume":"55","author":"S Unal","year":"2010","unstructured":"Unal S, et al. Stanozolol treatment for successful prevention of attacks of severe primary cryofibrinogenemia. Pediatr Blood Cancer. 2010;55(1):174\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"228_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02286781","volume":"10","author":"AE Williamson","year":"1996","unstructured":"Williamson AE, Cone LA, Huard Ii GS. Spontaneous necrosis of the skin associated with cryofibrinogenemia, cryoglobulinemia, and homocystinuria. Ann Vasc Surg. 1996;10(4):365\u20139.","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"228_CR47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/archderm.127.1.115","volume":"127","author":"AD Klein","year":"1991","unstructured":"Klein AD, Kerdel FA. Purpura and recurrent ulcers on the lower extremities. Arch Dermatol. 1991;127(1):115\u20138.","journal-title":"Arch Dermatol"},{"issue":"2","key":"228_CR48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0190-9622(95)90244-9","volume":"33","author":"T Helfman","year":"1995","unstructured":"Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol. 1995;33(2):254\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"228_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1742-1241.1976.tb07350.x","volume":"30","author":"H Gribbin","year":"1976","unstructured":"Gribbin H, Matts S. Mode of action and use of anabolic steroids. Br J Clin Pract. 1976;30(1):3\u20135 (passim).","journal-title":"Br J Clin Pract"},{"issue":"5","key":"228_CR50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1972.tb05701.x","volume":"22","author":"J Davidson","year":"1972","unstructured":"Davidson J, et al. Fibrinolytic enhancement by stanozolol: a double blind trial. Br J Haematol. 1972;22(5):543\u201359.","journal-title":"Br J Haematol"},{"issue":"6","key":"228_CR51","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1046\/j.1523-1747.1998.00431.x","volume":"111","author":"V Falanga","year":"1998","unstructured":"Falanga V, et al. Stimulation of collagen synthesis by the anabolic steroid stanozolol. J Investig Dermatol. 1998;111(6):1193\u20137.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"228_CR52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2478\/s11535-008-0058-x","volume":"4","author":"S Marshall-Gradisnik","year":"2009","unstructured":"Marshall-Gradisnik S, et al. Anabolic androgenic steroids effects on the immune system: a review. Open Life Sci. 2009;4(1):19\u201333.","journal-title":"Open Life Sci"},{"issue":"1","key":"228_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0960-0760(90)90374-T","volume":"37","author":"CL Mendenhall","year":"1990","unstructured":"Mendenhall CL, et al. Anabolic steroid effects on immune function: differences between analogues. J Steroid Biochem Mol Biol. 1990;37(1):71\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"228_CR54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/dth.12225","volume":"28","author":"PR Criado","year":"2015","unstructured":"Criado PR, et al. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol. Dermatol Ther. 2015;28(4):248\u201353.","journal-title":"Dermatol Ther"},{"issue":"3","key":"228_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246113","volume":"194","author":"G-H Hsiao","year":"1997","unstructured":"Hsiao G-H, Chiu H-C. Low-dose danazol in the treatment of livedoid vasculitis. Dermatology. 1997;194(3):251\u20135.","journal-title":"Dermatology"},{"issue":"14\u201315","key":"228_CR56","first-page":"383","volume":"143","author":"G Lowe","year":"1992","unstructured":"Lowe G. Anabolic steroids and fibrinolysis. Wien Med Wochenschr. 1992;143(14\u201315):383\u20135.","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"228_CR57","first-page":"32","volume":"6","author":"E Rachmilewitz","year":"1969","unstructured":"Rachmilewitz E, Sacks M, Zlotnick A. Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci. 1969;6(1):32\u201343.","journal-title":"Isr J Med Sci"},{"issue":"10","key":"228_CR58","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)60922-7","volume":"67","author":"KL Klein","year":"1992","unstructured":"Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc. 1992;67(10):923\u201333.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"228_CR59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/0128071-200910010-00007","volume":"10","author":"M Chartier","year":"2009","unstructured":"Chartier M, Falanga V. Healing of Ulcers due to Cryofibrinogenemia with Colchicine and High-Dose Pentoxifylline. Am J Clin Dermatol. 2009;10(1):39\u201342.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"228_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.142.1.75","volume":"142","author":"CE Browning","year":"2006","unstructured":"Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol. 2006;142(1):75\u20138.","journal-title":"Arch Dermatol"},{"key":"228_CR61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.1979.tb15293.x","volume":"101","author":"P Copeman","year":"1979","unstructured":"Copeman P. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis. Br J Dermatol. 1979;101:57.","journal-title":"Br J Dermatol"},{"issue":"1","key":"228_CR62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1526-0968.1999.00146.x","volume":"3","author":"GA Siami","year":"1999","unstructured":"Siami GA, Siami FS. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstr\u00f6m\u2019s macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis. Ther Apher. 1999;3(1):8\u201319.","journal-title":"Ther Apher"},{"issue":"3","key":"228_CR63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1744-9987.1998.tb00109.x","volume":"2","author":"GA Siami","year":"1998","unstructured":"Siami GA, Siami FS. Cryofiltration apheresis in the United States. Ther Apher. 1998;2(3):228\u201335.","journal-title":"Ther Apher"},{"issue":"1","key":"228_CR64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1744-9987.1997.tb00015.x","volume":"1","author":"FS Siami","year":"1997","unstructured":"Siami FS, Siami GA. Cryofiltration apheresis in the treatment of cryoprecipitate induced diseases. Ther Apher. 1997;1(1):58\u201362.","journal-title":"Ther Apher"},{"issue":"1","key":"228_CR65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/wound.2014.0586","volume":"5","author":"G Dabiri","year":"2016","unstructured":"Dabiri G, Damstetter E, Phillips T. Choosing a wound dressing based on common wound characteristics. Adv Wound Care (New Rochelle). 2016;5(1):32\u201341.","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"228_CR66","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.ejim.2015.10.008","volume":"28","author":"M Michaud","year":"2016","unstructured":"Michaud M, et al. Cryofibrinogenemia and risk of cancer in cryoglobulinemic patients without vasculitis criteria. Eur J Intern Med. 2016;28:e10\u20132.","journal-title":"Eur J Intern Med"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0228-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0228-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0228-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T12:10:20Z","timestamp":1692533420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0228-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0228-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"type":"print","value":"1175-0561"},{"type":"electronic","value":"1179-1888"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}